AzTrials
AzTrials

Ambulatory SurgeryPhase 4Propo-FaimNCT02272166

Effects of Propofol on Early Recovery of Hunger After Surgery

A Phase 4 study testing propofol and Sevoflurane in people with Ambulatory Surgery and Anesthesia, run by University Hospital, Rouen at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Recovery of hunger is a source of comfort for patients after general anesthesia. Moreover, this aspect of post-operative period is often required for discharging patients from hospital after ambulatory surgery. Read more about this study

Who is it for?
Ages 18 to 45 years, women only
Conditions the study is for
Ambulatory Surgery, Anesthesia, Energy Expenditure
What is being tested?
propofol and Sevoflurane
Could I receive a placebo?
No, everyone receives an active treatment
How many people
116 participants
Where
1 siteFrance
Study dates
Nov 2014to Jul 2016
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • 18-45 years old women
  • American Society of Anesthesiologists (ASA) score 1-2
  • Affiliated to a social security system
  • Undergoing an ambulatory surgery during more than 15 minutes with general anesthesia and control of upper airways (tracheal intubation or supraglottic mask or facial mask ventilation) for oocytes punction before in vitro fertilization
  • General anesthesia occuring between 8 and 10 am with respect of pre-operative fasting rules
  • APFEL risk score for nausea and vomiting ≤ 2/4
  • Ability to understand and read french
  • Signature of understood consent

Who cannot join

  • Other surgery than oocytes punction
  • Cognitive dysfunction
  • Undernutrition or risk factor of undernutrition (evolutive neoplasia, chronic alcoholism …)
  • BMI ≥ 35 kg/m²
  • Eating disorders
  • Diabetes mellitus
Show all 15Show fewer
  • Chronic treatment with drugs modifying feeding behavior :
  • Benzodiazepines
  • Inhibitors of serotonin reuptake
  • Others
  • Non respect of pre-operative fasting rules
  • Indication for rapid sequence induction (gastro-oesophageal reflux, absence of gastric emptying …)
  • Contraindication to propofol (allergia to propofol, soybean or peanuts, past history of propofol infusion syndrome, unstable cardiovascular disease) or to sevoflurane (past history of malignant hyperthermia, epilepsy or liver disorders after administration of a halogenated anesthetic)
  • Pregnant or breastfeeding woman
  • Involvement in another clinical trial under 4 previous weeks

Trial locations and contacts

1 site in 1 country.

France1 site
  • Rouen University Hospital

    Rouen, 76031

Other trials in France

About this study

Official title: Effects of Propofol on Early Recovery of Hunger After Ambulatory Surgery Compared With Sevoflurane

Recovery of hunger is a source of comfort for patients after general anesthesia. Moreover, this aspect of post-operative period is often required for discharging patients from hospital after ambulatory surgery. Indeed, this item is part of a multi-parameter score (Chung score) whose validation evaluates patient's ability to return home.

The impact of anesthetics on hunger is largely unknown but few studies suggest an orexigenic effect of propofol compared to halogenated gases. These studies had neither the power nor the methodology to answer the question. The aim of our study is to evaluate the impact of propofol versus sevoflurane on early recovery of hunger after ambulatory surgery.

Being tested
propofol, Sevoflurane

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • propofolDrug

    Also called diprivan, 2,6-bis(propan-2-yl)phénol

  • SevofluraneDrug

    Also called Sevorane, 1,1,1,3,3,3-hexafluoro-2-(fluorométhoxy)propane

Study groups in NCT02272166
Study groupRoleWhat they receive
propofolActive comparatorHypnotic used in this arm is exclusively intra-venous propofol.
Receives: Drug: propofol
sevofluraneActive comparatorHypnotic used in this arm is exclusively inhaled sevoflurane.
Receives: Drug: Sevoflurane

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time before recovery of hunger after general anesthesia

    Time before appearance of of hunger (evaluated by a score above 50/100 mm on analogic visual scale) after the end of hypnotic administration (propofol or sevoflurane).

    Measured: 1-4 hours

Secondary outcomes (6)
  1. Feeding comfort

    Amount of food intake evaluated by a specific scale

    Measured: 1-4 hours

  2. Post operative nausea and vomiting

    Measured: 1-4 hours

  3. Validation of Chung score

    Time needed to obtain a Chung score superior or equal to 9/10, permitting the patient to return home

    Measured: 1-4 hours

  4. Change in plasmatic leptin level

    Change in plasmatic leptin level (expressed in ng/ml) at the end of anesthesia, one and two hours later, compared with pre-operative value for each patient. Dosage is realized by ELISA method.

    Measured: 0-3 hours

  5. Change in plasmatic insulin level

    Change in plasmatic insulin level (expressed in microU/ml) at the end of anesthesia, one and two hours later, compared with pre-operative value for each patient. Dosage is realized by ELISA method.

    Measured: 0-3 hours

  6. Change in plasmatic ghrelin level

    Change in plasmatic ghrelin level (expressed in pg/ml) at the end of anesthesia, one and two hours later, compared with pre-operative value for each patient. Dosage is realized by ELISA method.

    Measured: 0-3 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Oct 2014 (estimated)
  2. Study startNov 2014
  3. Primary completionJul 2016
  4. Study completionJul 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
116 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02272166
Sponsor's protocol ID
2014/088/HP
Acronym
Propo-Faim
Status last verified
Dec 2017
First submitted
15 Oct 2014
Last updated
21 Dec 2017
Results posted
No
Data monitoring committee
Yes

Publications

  • Besnier E, Perdrix A, Gillibert A, Selim J, Froemer B, Ghemired A, Berby B, Rives N, Dureuil B, Clavier T, Compere V. Postoperative hunger after outpatient surgery in patients anesthetized with propofol vs sevoflurane: a randomized-controlled trial. Can J Anaesth. 2020 May;67(5):550-559. doi: 10.1007/s12630-020-01584-w. Epub 2020 Jan 29.

    PubMed 31997087

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing propofol and Sevoflurane in people with Ambulatory Surgery and Anesthesia, run by University Hospital, Rouen at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Dec 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time before recovery of hunger after general anesthesia (time frame: 1-4 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02272166, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Dec 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in